Europe PMCopen access
The case for an Epstein-Barr virus vaccine: Lessons from its link to systemic lupus erythematosus
systemic lupus erythematosus, Vaccine Development, Epstein–barr Virus, Viral Latency, Autoreactive B Cells, Autoimmune Disease Prevention
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 120197
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.